Tag Archives: issue 43

The University of Oxford recently conducted a groundbreaking clinical trial, marking the initiation of the first-in-human testing phase for the ChAdOx1 NipahB vaccine. Developed by researchers at the University’s Pandemic Sciences Institute, this critical trial, led by the Oxford Vaccine Group, is financially backed by the Coalition for Epidemic Preparedness …

Suresh Manandhar, PhD CEO and Chief Scientist Wiseyak AI need not be 100% accurate but we need AI systems to have 0% (or close) false negatives. In Wiseyak we are focused on data quality and data interoperability… For this reason, we are trying to obtain accurate medical data and ensure …